Mechanical induction of PGE2 in osteocytes blocks glucocorticoid-induced apoptosis through both the β-catenin and PKA pathways

Abstract

Glucocorticoids are known to induce osteocyte apoptosis, whereas mechanical loading has been shown to sustain osteocyte viability. Here we show that mechanical loading in the form of fluid-flow shear stress blocks dexamethasone-induced apoptosis of osteocyte-like cells (MLO-Y4). Prostaglandin E2 (PGE2), a rapidly induced signaling molecule produced by osteocytes, was shown to be protective against dexamethasone-induced apoptosis, whereas indomethacin reversed the antiapoptotic effects of shear stress. This protective effect of shear stress was mediated through EP2 and EP4 receptors, leading to activation of the cAMP/protein kinase A signaling pathway. Activation of phosphatidylinositol 3-kinase, an inhibitor of glycogen synthesis kinase 3, also occurred, leading to the nuclear translocation of β-catenin, an important signal transducer of the Wnt signaling pathway. Both shear stress and prostaglandin increased the phosphorylation of glycogen synthesis kinase 3 α/β. Lithium chloride, an activator of the Wnt pathway, also was protective against glucocorticoid-induced apoptosis. Whereas it is known that mechanical loading increases cyclooxygenase-2 and EP2 receptor expression and prostaglandin production, dexamethasone was shown to inhibit expression of these components of the prostaglandin pathway and to reduce β-catenin protein expression. β-catenin siRNA knockdown experiments abrogated the protective effects of PGE2, confirming the central role of β-catenin in mediating the protection against dexamethasone-induced cell death. Our data support a central role for PGE2 acting through the cAMP/PKA and β-catenin signaling pathways in the protection of osteocyte apoptosis by fluid-flow shear stress. © 2010 American Society for Bone and Mineral Research.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 60

1. 1.

   Osteoporosis prevention, diagnosis, and therapy. NIH Consensus Statement. 2000;17:1-45.

   Not in our library

2. 2.

   Dovio A, Perazzolo L, Osella G, et al. Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis. J Clin Endocrinol Metab. 2004;89:4923-4928.

   Not in our library10.1210/jc.2004-0164

3. 3.

   Dalle Carbonare L, Arlot ME, Chavassieux PM, Roux JP, Portero NR, Meunier PJ. Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis. J Bone Miner Res. 2001;16:97-103.

   Not in our library10.1359/jbmr.2001.16.1.97

4. 4.

   Dempster DW. Bone histomorphometry in glucocorticoid-induced osteoporosis. J Bone Miner Res. 1989;4:137-141.

   Not in our library10.1002/jbmr.5650040202

5. 5.

   Manolagas SC, Weinstein RS. New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res. 1999;14:1061-1066.

   Not in our library10.1359/jbmr.1999.14.7.1061

6. 6.

   Lane NE, Yao W, Balooch M, et al. Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice. J Bone Miner Res. 2006;21:466-476.

   Not in our library10.1359/jbmr.051103

7. 7.

   Bonewald LF. Osteocytes as dynamic, multifunctional cells. Ann N Y Acad Sci. 2007;1116:281-290.

   Not in our library10.1196/annals.1402.018

8. 8.

   Taylor D, Hazenberg J, Lee TC. The cellular transducer in bone: What is it? Technol Health Care. 2006;14:367-377.

   Not in our library

9. 9.

   Vezeridis PS, Semeins CM, Chen Q, Klein-Nulend J. Osteocytes subjected to pulsating fluid flow regulate osteoblast proliferation and differentiation. Biochem Biophys Res Commun. 2006;348:1082-1088.

   Not in our library10.1016/j.bbrc.2006.07.146

10. 10.

    Kogianni G, Mann V, Noble BS. Apoptotic bodies convey activity capable of initiating osteoclastogenesis and localized bone destruction. J Bone Miner Res. 2008;23:915-927.

    Not in our library10.1359/jbmr.080207

11. 11.

    Verborgt O, Gibson GJ, Schaffler MB. Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo. J Bone Miner Res. 2000;15:60-67.

    Not in our library10.1359/jbmr.2000.15.1.60

12. 12.

    Tatsumi S, Ishii K, Amizuka N, et al. Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab. 2007;5:464-475.

    Not in our library10.1016/j.cmet.2007.05.001

13. 13.

    Dunstan CR, Evans RA, Hills E, Wong SY, Higgs RJ. Bone death in hip fracture in the elderly. Calcif Tissue Int. 1990;47:270-275.

    Not in our library10.1007/bf02555908

14. 14.

    Weinstein RS, Nicholas RW, Manolagas SC. Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. J Clin Endocrinol Metab. 2000;85:2907-2912.

    Not in our library10.1210/jcem.85.8.6714

15. 15.

    Manolagas SC. Corticosteroids and fractures: a close encounter of the third cell kind. J Bone Miner Res. 2000;15:1001-1005.

    Not in our library10.1359/jbmr.2000.15.6.1001

16. 16.

    Aguirre JI, Plotkin LI, Stewart SA, et al. Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss. J Bone Miner Res. 2006;21:605-615.

    Not in our library10.1359/jbmr.060107

17. 17.

    Noble BS, Peet N, Stevens HY, et al. Mechanical loading: biphasic osteocyte survival and targeting of osteoclasts for bone destruction in rat cortical bone. Am J Physiol Cell Physiol. 2003;284:C934-C943.

    Not in our library10.1152/ajpcell.00234.2002

18. 18.

    Plotkin LI, Mathov I, Aguirre JI, Parfitt AM, Manolagas SC, Bellido T. Mechanical stimulation prevents osteocyte apoptosis: requirement of integrins, Src kinases, and ERKs. Am J Physiol Cell Physiol. 2005;289:C633-C643.

    Not in our library10.1152/ajpcell.00278.2004

19. 19.

    Weinbaum S, Cowin SC, Zeng Y. A model for the excitation of osteocytes by mechanical loading-induced bone fluid shear stresses. J Biomech. 1994;27:339-360.

    Not in our library10.1016/0021-9290(94)90010-8

20. 20.

    Hillsley MV, Frangos JA. Bone tissue engineering: the role of interstitial fluid flow. Biotechnol Bioeng. 1994;43:573-581.

    Not in our library10.1002/bit.260430706

21. 21.

    Knothe Tate ML. “Whither flows the fluid in bone?” An osteocyte's perspective. J Biomech. 2003;36:1409-1424.

    Not in our library10.1016/s0021-9290(03)00123-4

22. 22.

    Klein-Nulend J, van der Plas A, Semeins CM, et al. Sensitivity of osteocytes to biomechanical stress in vitro. Faseb J. 1995;9:441-445.

    Not in our library10.1096/fasebj.9.5.7896017

23. 23.

    Johnson ML, Kamel MA, Kim-Weroha NA, Holladay B, Kotha SP. Greater sensitivity of osteocytes to shear stress as compared to osteoblasts: PGE2 production and Wnt/b-catenin signaling. J Bone Miner Res. 2007;22(Suppl 1):S375.

    Not in our library

24. 24.

    Kamel MA, Kitase Y, Kim-Weroha NA, et al. Fluid flow shear stress and prostaglandin E2 activates b-catenin signaling in MLO-Y4 osteocytic and 2T3 osteoblastic cells. J Bone Miner Res. 2007;22(Suppl 1):S375.

    Not in our library

25. 25.

    Xia X, Batra N, Shi Q, Bonewald LF, Sprague E, Jiang JX. Prostaglandin promotion of osteocyte gap junction function through transcriptional regulation of connexin 43 by glycogen synthase kinase 3/b-catenin signaling. Mole Cell Biol. 2010;30:206-219.

    Not in our library10.1128/mcb.01844-08

26. 26.

    Lin CL, Wang JY, Ko JY, et al. Superoxide destabilization of beta-catenin augments apoptosis of high-glucose-stressed mesangial cells. Endocrinology. 2008;149:2934-2942.

    Not in our library10.1210/en.2007-1372

27. 27.

    Lin CL, Wang JY, Huang YT, Kuo YH, Surendran K, Wang FS. Wnt/beta-catenin signaling modulates survival of high glucose-stressed mesangial cells. J Am Soc Nephrol. 2006;17:2812-2820.

    Not in our library10.1681/asn.2005121355

28. 28.

    Xie H, Huang Z, Sadim MS, Sun Z. Stabilized beta-catenin extends thymocyte survival by up-regulating Bcl-xL. J Immunol. 2005;175:7981-7988.

    Not in our library10.4049/jimmunol.175.12.7981

29. 29.

    Kato Y, Windle JJ, Koop BA, Mundy GR, Bonewald LF. Establishment of an osteocyte-like cell line, MLO-Y4. J Bone Miner Res. 1997;12:2014-2023.

    Not in our library10.1359/jbmr.1997.12.12.2014

30. 30.

    Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest. 1999;104:1363-1374.

    Not in our library10.1172/jci6800

31. 31.

    Ajubi NE, Klein-Nulend J, Nijweide PJ, Vrijheid-Lammers T, Alblas MJ, Burger EH. Pulsating fluid flow increases prostaglandin production by cultured chicken osteocytes—a cytoskeleton-dependent process. Biochem Biophys Res Commun. 1996;225:62-68.

    Not in our library10.1006/bbrc.1996.1131

32. 32.

    Cherian PP, Siller-Jackson AJ, Gu S, et al. Mechanical strain opens connexin 43 hemichannels in osteocytes: a novel mechanism for the release of prostaglandin. Mol Biol Cell. 2005;16:3100-3106.

    Not in our library10.1091/mbc.e04-10-0912

33. 33.

    Sugimoto Y, Narumiya S. Prostaglandin E receptors. J Biol Chem. 2007;282:11613-11617.

    Not in our library10.1074/jbc.r600038200

34. 34.

    Fujino H, West KA, Regan JW. Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. J Biol Chem. 2002;277:2614-2619.

    Not in our library10.1074/jbc.m109440200

35. 35.

    Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science. 2005;310:1504-1510.

    Not in our library10.1126/science.1116221

36. 36.

    Shao J, Jung C, Liu C, Sheng H. Prostaglandin E2 Stimulates the beta-catenin/T cell factor-dependent transcription in colon cancer. J Biol Chem. 2005;280:26565-26572.

    Not in our library10.1074/jbc.m413056200

37. 37.

    Jensen J, Brennesvik EO, Lai YC, Shepherd PR. GSK-3beta regulation in skeletal muscles by adrenaline and insulevidence that PKA and PKB regulate different pools of GSK-3. Cell Signal. 2007;19:204-210.

    Not in our library10.1016/j.cellsig.2006.06.006

38. 38.

    Li M, Wang X, Meintzer MK, Laessig T, Birnbaum MJ, Heidenreich KA. Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta. Mol Cell Biol. 2000;20:9356-9363.

    Not in our library10.1128/mcb.20.24.9356-9363.2000

39. 39.

    Cherian PP, Cheng B, Gu S, Sprague E, Bonewald LF, Jiang JX. Effects of mechanical strain on the function of Gap junctions in osteocytes are mediated through the prostaglandin EP2 receptor. J Biol Chem. 2003;278:43146-43156.

    Not in our library10.1074/jbc.m302993200

40. 40.

    Delfino DV, Agostini M, Spinicelli S, Vito P, Riccardi C. Decrease of Bcl-xL and augmentation of thymocyte apoptosis in GILZ overexpressing transgenic mice. Blood. 2004;104:4134-4141.

    Not in our library10.1182/blood-2004-03-0920

Cited by papers we hold 6

• Alveolar socket healing in 5-lipoxygenase knockout aged female mice treated or not with high dose of zoledronic acid · 2021
  Not checked
• Osteocyte apoptosis: the roles and key molecular mechanisms in resorption-related bone diseases · 2020
  No notice
• Commentary: Evaluating the Role of Seagrass in Cenozoic CO2 Variations · 2017
  Not checked
• Sclerostin's role in bone's adaptive response to mechanical loading · 2017
  No notice
• Load regulates bone formation and Sclerostin expression through a TGFβ-dependent mechanism. · 2013
  Not checked
• The amazing osteocyte · 2010
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.